Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Tibolone and risk of gynecological hormone sensitive cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Does HPV status influence survival after vulvar cancer?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Labour market affiliation among non-bullied colleagues at work units with reported bullying

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Burkitt lymphoma (BL) is a malignant disease, which is frequently found in areas with holoendemic Plasmodium falciparum malaria. We have previously found that the VAR2CSA protein is present on malaria-infected erythrocytes and facilitates a highly specific binding to the placenta. ofCS is absent in other non-malignant tissues and thus VAR2CSA generally facilitates parasite sequestration and accumulation in pregnant women. In this study, we show that the specific receptor for VAR2CSA, the oncofetal chondroitin sulfate (ofCS), is likewise present in BL tissue and cell lines. We therefore explored whether ofCS in BL could act as anchor site for VAR2CSA-expressing infected erythrocytes. In contrast to the placenta, we found no evidence of in vivo sequestering of infected erythrocytes in the BL tissue. Furthermore, we found VAR2CSA-specific antibody titers in children with endemic BL to be lower than in control children from the same malaria endemic region. The abundant presence of ofCS in BL tissue and the absence of ofCS in non-malignant tissue encouraged us to examine whether recombinant VAR2CSA could be used to target BL. We confirmed the binding of VAR2CSA to BL-derived cells and showed that a VAR2CSA drug conjugate efficiently killed the BL-derived cell lines in vitro. These results identify ofCS as a novel therapeutic BL target and highlight how VAR2CSA could be used as a tool for the discovery of novel approaches for directing BL therapy.

Original languageEnglish
JournalRadiation Oncology Investigations
Volume140
Issue number7
Pages (from-to)1597-1608
Number of pages12
ISSN0020-7136
DOIs
Publication statusPublished - 1 Apr 2017

    Research areas

  • Adolescent, Antibodies, Protozoan, Antigens, Neoplasm, Antigens, Protozoan, Burkitt Lymphoma, Cell Line, Tumor, Child, Child, Preschool, Chondroitin Sulfates, Erythrocytes, Female, Humans, Immunoglobulin G, Malaria, Falciparum, Male, Placenta, Plasmodium falciparum, Pregnancy, Proteoglycans, Recombinant Proteins, Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Intramural

ID: 52819952